Pfam Domains GO Terms
| DUF1053 |
| Guanylate cyc |
| adenylate cyclase activity |
| cAMP biosynthetic process |
| cellular response to lithium ion |
| cellular response to ethanol |
| negative regulation of cytokine production involved in inflammatory response |
| activation of protein kinase A activity |
| response to lithium ion |
| cAMP metabolic process |
| cyclic purine nucleotide metabolic process |
| cyclic nucleotide biosynthetic process |
| cellular response to glucagon stimulus |
| renal water homeostasis |
| response to glucagon |
| activation of adenylate cyclase activity |
| regulation of cytokine production involved in inflammatory response |
| cyclic nucleotide metabolic process |
| maternal process involved in female pregnancy |
| multicellular organismal water homeostasis |
| water homeostasis |
| cellular response to alcohol |
| adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
| renal system process |
| cellular response to antibiotic |
| response to ethanol |
| adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| negative regulation of inflammatory response |
| cAMP-mediated signaling |
| purine ribonucleotide biosynthetic process |
| purine nucleotide biosynthetic process |
| regulation of adaptive immune response |
| ribonucleotide biosynthetic process |
| ribose phosphate biosynthetic process |
| purine-containing compound biosynthetic process |
| cyclic-nucleotide-mediated signaling |
| female pregnancy |
| cellular response to metal ion |
| negative regulation of defense response |
| adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
| multi-multicellular organism process |
| cellular response to toxic substance |
| cellular response to inorganic substance |
| response to alcohol |
| nucleotide biosynthetic process |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| nucleoside phosphate biosynthetic process |
| cellular response to peptide hormone stimulus |
| negative regulation of cytokine production |
| response to antibiotic |
| purine ribonucleotide metabolic process |
| multicellular organismal homeostasis |
| ribonucleotide metabolic process |
| cellular response to peptide |
| activation of protein kinase activity |
| purine nucleotide metabolic process |
| ribose phosphate metabolic process |
| second-messenger-mediated signaling |
| regulation of inflammatory response |
| negative regulation of response to external stimulus |
| purine-containing compound metabolic process |
| response to metal ion |
| response to peptide hormone |
| cellular response to drug |
| nucleotide metabolic process |
| nucleoside phosphate metabolic process |
| response to peptide |
| regulation of body fluid levels |
| response to toxic substance |
| positive regulation of protein kinase activity |
| response to inorganic substance |
| organophosphate biosynthetic process |
| nucleobase-containing small molecule metabolic process |
| positive regulation of kinase activity |
| cellular response to organonitrogen compound |
| cellular response to hormone stimulus |
| carbohydrate derivative biosynthetic process |
| positive regulation of transferase activity |
| cellular response to nitrogen compound |
| regulation of cytokine production |
| regulation of defense response |
| regulation of protein kinase activity |
| multicellular organismal reproductive process |
| multicellular organism reproduction |
| regulation of kinase activity |
| organophosphate metabolic process |
| response to hormone |
| regulation of transferase activity |
| multi-organism reproductive process |
| response to organonitrogen compound |
| positive regulation of protein phosphorylation |
| response to drug |
| carbohydrate derivative metabolic process |
| cellular response to oxygen-containing compound |
| positive regulation of phosphorylation |
| response to nitrogen compound |
| regulation of response to external stimulus |
| nucleobase-containing compound biosynthetic process |
| chemical homeostasis |
| positive regulation of phosphorus metabolic process |
| positive regulation of phosphate metabolic process |
| regulation of immune response |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| negative regulation of multicellular organismal process |
| cellular response to endogenous stimulus |
| positive regulation of protein modification process |
| organic cyclic compound biosynthetic process |
| G protein-coupled receptor signaling pathway |
| integral component of plasma membrane |
| organonitrogen compound biosynthetic process |
| reproductive process |
| reproduction |
| positive regulation of catalytic activity |
| regulation of protein phosphorylation |
| response to endogenous stimulus |
| regulation of response to stress |
| ATP binding |
| response to oxygen-containing compound |
| regulation of phosphorylation |
| positive regulation of cellular protein metabolic process |
| negative regulation of response to stimulus |
| cellular nitrogen compound biosynthetic process |
| homeostatic process |
| regulation of immune system process |
| intracellular signal transduction |
| positive regulation of protein metabolic process |
| small molecule metabolic process |
| positive regulation of molecular function |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| regulation of protein modification process |
| system process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Screen | Score |
|---|---|
| Aphidicolin 0.4μM R08 exp440 | -1.81 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution